Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boshoff

Showing results (511-520 of 568) with videos related to

Pageof 57
Sort By:
ACS Chemical Biology|August 15, 2017
Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate ReductaseJohn P Santa Maria, Yumi Park, Lihu Yang, et al.
Journal of Medicinal Chemistry|September 8, 2018
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against MalariaXu Wang, Rachel L Edwards, Haley Ball, et al.
Molecular Plant-Microbe Interactions : MPMI|November 13, 2023
Genome-Enabled Analysis of Population Dynamics and Virulence-Associated Loci in the Oat Crown Rust Fungus <i>Puccinia coronata</i> f. sp. <i>avenae</i>Tim C Hewitt, Eva C Henningsen, Danilo Pereira, et al.
Nucleic Acids Research|July 1, 2020
Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modificationSherine E Thomas, Andrew J Whitehouse, Karen Brown, et al.
Genome Medicine|May 31, 2013
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsMatthias Lechner, Garrett M Frampton, Tim Fenton, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensisSuresh Kumar Gorla, Yan Zhang, Meaghan M Rabideau, et al.
ACS Infectious Diseases|June 13, 2023
MEPicides: α,β-unsaturated Fosmidomycin <i>N</i>-Acyl Analogs as Efficient Inhibitors of <i>Plasmodium falciparum</i> 1-Deoxy-d-xylulose-5-phosphate reductoisomeraseXu Wang, Rachel L Edwards, Haley S Ball, et al.
Journal of Medicinal Chemistry|July 14, 2025
Fragment-Based Development of Small Molecule Inhibitors Targeting <i>Mycobacterium tuberculosis</i> Cholesterol MetabolismMadeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert, et al.
Pageof 57

Showing results (511-520 of 568) with videos related to

Sort By:
Pageof 57
ACS Chemical Biology|August 15, 2017
Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate ReductaseJohn P Santa Maria, Yumi Park, Lihu Yang, et al.
Journal of Medicinal Chemistry|September 8, 2018
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against MalariaXu Wang, Rachel L Edwards, Haley Ball, et al.
Molecular Plant-Microbe Interactions : MPMI|November 13, 2023
Genome-Enabled Analysis of Population Dynamics and Virulence-Associated Loci in the Oat Crown Rust Fungus <i>Puccinia coronata</i> f. sp. <i>avenae</i>Tim C Hewitt, Eva C Henningsen, Danilo Pereira, et al.
Nucleic Acids Research|July 1, 2020
Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modificationSherine E Thomas, Andrew J Whitehouse, Karen Brown, et al.
Genome Medicine|May 31, 2013
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsMatthias Lechner, Garrett M Frampton, Tim Fenton, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>Melissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensisSuresh Kumar Gorla, Yan Zhang, Meaghan M Rabideau, et al.
ACS Infectious Diseases|June 13, 2023
MEPicides: α,β-unsaturated Fosmidomycin <i>N</i>-Acyl Analogs as Efficient Inhibitors of <i>Plasmodium falciparum</i> 1-Deoxy-d-xylulose-5-phosphate reductoisomeraseXu Wang, Rachel L Edwards, Haley S Ball, et al.
Journal of Medicinal Chemistry|July 14, 2025
Fragment-Based Development of Small Molecule Inhibitors Targeting <i>Mycobacterium tuberculosis</i> Cholesterol MetabolismMadeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert, et al.
Pageof 57